Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Africa CDC: Roll Out AstraZeneca’s COVID-19 Vaccine On Continent — Except In Countries Where B-1351 Variant Dominates 11/02/2021 Paul Adepoju In the next two weeks, distribution of millions of doses of the Oxford/AstraZeneca SARS-COV2 to health workers across Africa will get underway, said the director of the Africa Centers for Disease Control in a joint press briefing with the WHO Regional Office for Africa on Thursday. CDC Director John Nkengasong told Health Policy Watch that […] Continue reading -> [EXCLUSIVE] Little Vials, Big Crime: Criminals Primed For Onslaught On Africa’s Vaccines 11/02/2021 Darren Taylor/Bhekisisa Weak medicine regulators in Africa mean the continent is vulnerable to falsified COVID vaccines being circulated. Sources at international anti-crime agencies argue that Africa’s strong trade routes with China and India are going to allow criminals to introduce shipments of falsified vaccines into supply chains. The World Health Organisation says the global market for substandard […] Continue reading -> Vaccine Not A Silver Bullet – WHO Officials Plead With Public To Maintain Other “Public Health Measures” 10/02/2021 Raisa Santos New York City – Echoing a message issued by WHO’s Geneva office today, WHO officials in the Agency’s Americas Regional Office stressed that stronger public health measures are desperately needed, alongside vaccines, to reduce transmission and the risk of even more variants emerging. “The vaccine is not a silver bullet. The vaccine will not stop […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Africa CDC: Roll Out AstraZeneca’s COVID-19 Vaccine On Continent — Except In Countries Where B-1351 Variant Dominates 11/02/2021 Paul Adepoju In the next two weeks, distribution of millions of doses of the Oxford/AstraZeneca SARS-COV2 to health workers across Africa will get underway, said the director of the Africa Centers for Disease Control in a joint press briefing with the WHO Regional Office for Africa on Thursday. CDC Director John Nkengasong told Health Policy Watch that […] Continue reading -> [EXCLUSIVE] Little Vials, Big Crime: Criminals Primed For Onslaught On Africa’s Vaccines 11/02/2021 Darren Taylor/Bhekisisa Weak medicine regulators in Africa mean the continent is vulnerable to falsified COVID vaccines being circulated. Sources at international anti-crime agencies argue that Africa’s strong trade routes with China and India are going to allow criminals to introduce shipments of falsified vaccines into supply chains. The World Health Organisation says the global market for substandard […] Continue reading -> Vaccine Not A Silver Bullet – WHO Officials Plead With Public To Maintain Other “Public Health Measures” 10/02/2021 Raisa Santos New York City – Echoing a message issued by WHO’s Geneva office today, WHO officials in the Agency’s Americas Regional Office stressed that stronger public health measures are desperately needed, alongside vaccines, to reduce transmission and the risk of even more variants emerging. “The vaccine is not a silver bullet. The vaccine will not stop […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa CDC: Roll Out AstraZeneca’s COVID-19 Vaccine On Continent — Except In Countries Where B-1351 Variant Dominates 11/02/2021 Paul Adepoju In the next two weeks, distribution of millions of doses of the Oxford/AstraZeneca SARS-COV2 to health workers across Africa will get underway, said the director of the Africa Centers for Disease Control in a joint press briefing with the WHO Regional Office for Africa on Thursday. CDC Director John Nkengasong told Health Policy Watch that […] Continue reading -> [EXCLUSIVE] Little Vials, Big Crime: Criminals Primed For Onslaught On Africa’s Vaccines 11/02/2021 Darren Taylor/Bhekisisa Weak medicine regulators in Africa mean the continent is vulnerable to falsified COVID vaccines being circulated. Sources at international anti-crime agencies argue that Africa’s strong trade routes with China and India are going to allow criminals to introduce shipments of falsified vaccines into supply chains. The World Health Organisation says the global market for substandard […] Continue reading -> Vaccine Not A Silver Bullet – WHO Officials Plead With Public To Maintain Other “Public Health Measures” 10/02/2021 Raisa Santos New York City – Echoing a message issued by WHO’s Geneva office today, WHO officials in the Agency’s Americas Regional Office stressed that stronger public health measures are desperately needed, alongside vaccines, to reduce transmission and the risk of even more variants emerging. “The vaccine is not a silver bullet. The vaccine will not stop […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
[EXCLUSIVE] Little Vials, Big Crime: Criminals Primed For Onslaught On Africa’s Vaccines 11/02/2021 Darren Taylor/Bhekisisa Weak medicine regulators in Africa mean the continent is vulnerable to falsified COVID vaccines being circulated. Sources at international anti-crime agencies argue that Africa’s strong trade routes with China and India are going to allow criminals to introduce shipments of falsified vaccines into supply chains. The World Health Organisation says the global market for substandard […] Continue reading -> Vaccine Not A Silver Bullet – WHO Officials Plead With Public To Maintain Other “Public Health Measures” 10/02/2021 Raisa Santos New York City – Echoing a message issued by WHO’s Geneva office today, WHO officials in the Agency’s Americas Regional Office stressed that stronger public health measures are desperately needed, alongside vaccines, to reduce transmission and the risk of even more variants emerging. “The vaccine is not a silver bullet. The vaccine will not stop […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Vaccine Not A Silver Bullet – WHO Officials Plead With Public To Maintain Other “Public Health Measures” 10/02/2021 Raisa Santos New York City – Echoing a message issued by WHO’s Geneva office today, WHO officials in the Agency’s Americas Regional Office stressed that stronger public health measures are desperately needed, alongside vaccines, to reduce transmission and the risk of even more variants emerging. “The vaccine is not a silver bullet. The vaccine will not stop […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> Posts navigation Older postsNewer posts